Nucleic Acid Isolation Machine Sales

Nucleic Acid Isolation Machine Sales Market Outlook

The global nucleic acid isolation machine market is poised for significant growth, projected to reach USD 1.5 billion by 2035, with a compound annual growth rate (CAGR) of 8.5% from 2025 to 2035. The market's expansion can be attributed to the increasing prevalence of genetic disorders and infectious diseases, alongside a surge in research and development activities in biotechnology and pharmaceuticals. Furthermore, advancements in automation and technology are allowing for faster and more efficient nucleic acid isolation processes, enhancing the productivity of laboratories. The growing emphasis on personalized medicine and the rising demand for molecular diagnostics are further propelling the market's growth. Additionally, the academic sector's increasing focus on genomics and proteomics research is expected to further drive the demand for nucleic acid isolation machines in the coming years.

Growth Factor of the Market

Several factors are contributing to the growth of the nucleic acid isolation machine market. Firstly, the rising incidence of chronic and infectious diseases globally is pushing healthcare providers to invest in advanced diagnostic technologies, thereby increasing the demand for nucleic acid isolation products. Moreover, the rapid advancements in biotechnology and genomics are leading to a surge in research activities across various sectors, including academic and private research institutions. This trend is fostering the need for efficient nucleic acid extraction and purification technologies. Additionally, the growing trend of personalized medicine is driving the requirement for precise DNA and RNA analysis, which further enhances the market's growth prospects. The expansion of pharmaceutical companies focusing on drug development and the need for robust testing methodologies in clinical and laboratory settings are also significant growth drivers. Finally, the increasing availability and affordability of nucleic acid isolation machines are making them more accessible to a broader range of users.

Key Highlights of the Market

• The nucleic acid isolation machine market is projected to grow at a CAGR of 8.5% from 2025 to 2035.
• Automated nucleic acid isolation machines are witnessing the highest demand due to their efficiency and precision.
• Research institutes are the major application segment, accounting for over 35% of the market share.
• North America is leading the market due to the presence of key biotechnology firms and research institutions.
• Magnetic bead-based purification technologies are gaining popularity for their speed and simplicity in nucleic acid isolation.

By Product Type

Automated Nucleic Acid Isolation Machines:

Automated nucleic acid isolation machines represent a significant segment of the market, with their ability to streamline workflows and increase throughput in laboratories. These machines minimize human error and enhance reproducibility in nucleic acid extraction processes, making them indispensable in high-throughput environments such as clinical diagnostics and research facilities. The growing demand for automation in laboratories is pushing manufacturers to innovate and develop advanced systems that are user-friendly and capable of processing multiple samples simultaneously. Additionally, these machines often come equipped with integrated software that allows for seamless data management and analysis, further enhancing their appeal to users who require efficient and reliable results. As laboratories aim for greater efficiency and productivity, the adoption of automated nucleic acid isolation machines is expected to grow significantly over the forecast period.

Semi-Automated Nucleic Acid Isolation Machines:

Semi-automated nucleic acid isolation machines are becoming increasingly popular as they combine the benefits of automation with a level of user control, making them suitable for laboratories that do not require full automation. These machines allow researchers to maintain a hands-on approach while benefiting from the speed and efficiency of automated processes. This flexibility is especially appealing to smaller laboratories or those transitioning towards more automated systems. They offer a balance between cost-effectiveness and efficiency, making them an attractive option for a wider range of end-users. With the potential to adapt to various sample types and processing requirements, semi-automated machines are expected to capture a significant share of the nucleic acid isolation market.

Manual Nucleic Acid Isolation Kits:

Manual nucleic acid isolation kits continue to hold relevance in the market, particularly among academic institutions and laboratories with limited funding. These kits offer a cost-effective solution for laboratories that may not require the high throughput capabilities of automated systems. The simplicity and ease of use of manual kits make them ideal for educational purposes, where students can gain hands-on experience in nucleic acid extraction techniques. Furthermore, manual kits allow for flexibility in protocols, enabling researchers to customize their extraction methods based on specific requirements. As research into molecular biology and genetic analysis expands, the manual nucleic acid isolation kits are expected to maintain a steady demand, particularly in settings where budget constraints are a significant factor.

By Application

Research Institutes:

Research institutes are a dominant application segment within the nucleic acid isolation machine market, largely due to the increasing focus on genomics, proteomics, and molecular biology research. These institutions require advanced nucleic acid extraction technologies to facilitate their studies on gene expression, genetic variations, and other vital biological processes. The need for precise and reliable nucleic acid isolation methods is paramount, as the quality of the extracted nucleic acids directly influences the outcomes of subsequent analyses. As global research funding continues to support genomics and biotechnology initiatives, the demand for nucleic acid isolation machines in research institutes is expected to grow substantially, driving further advancements in this field.

Biotechnology Companies:

Biotechnology companies represent another key application segment, leveraging nucleic acid isolation machines for various purposes, including drug discovery and development, diagnostics, and genetic engineering. These companies rely heavily on efficient nucleic acid extraction methods to obtain high-quality DNA and RNA for cloning, sequencing, and other molecular techniques. As the biotechnology sector thrives, particularly in areas such as personalized medicine and synthetic biology, the demand for nucleic acid isolation machines is anticipated to rise. The continuous pursuit of innovations in biopharmaceuticals and the increasing number of clinical trials are also expected to bolster this market segment significantly.

Hospitals and Diagnostic Centers:

Hospitals and diagnostic centers play a vital role in the nucleic acid isolation machine market, as they are responsible for performing a vast array of diagnostic tests that require reliable nucleic acid extraction. The increasing prevalence of infectious diseases and genetic disorders necessitates accurate and efficient nucleic acid isolation methods for effective disease diagnosis and monitoring. These facilities are increasingly investing in advanced nucleic acid isolation technologies to enhance their diagnostic capabilities, thereby improving patient outcomes. Additionally, the integration of molecular diagnostics into routine clinical practice is driving the demand for nucleic acid isolation machines in these settings, making them indispensable for modern healthcare.

Pharmaceutical Companies:

Pharmaceutical companies are actively seeking nucleic acid isolation solutions to support their drug development processes, particularly in areas such as genomics and targeted therapies. These companies require high-quality nucleic acids for various applications, including biomarker discovery, validation, and the development of biologics. As the pharmaceutical industry continues to embrace personalized medicine approaches, the need for precise nucleic acid extraction and analysis is becoming increasingly critical. This trend is expected to drive significant growth in the nucleic acid isolation machine market, as pharmaceutical companies invest in advanced technologies to accelerate their research and development efforts.

Others:

Other applications of nucleic acid isolation machines encompass a range of sectors, including environmental testing, forensics, and food safety. These diverse applications highlight the versatility of nucleic acid isolation technologies and their importance in various fields. For instance, environmental laboratories utilize these machines to analyze genetic material from soil and water samples, aiding in biodiversity assessments and pollution studies. In the forensic sector, the ability to isolate DNA from crime scene samples is crucial for criminal investigations. Similarly, food safety applications involve the detection of pathogens and allergens through nucleic acid testing. As awareness of the importance of genetic analysis in these areas grows, the demand for nucleic acid isolation machines in these miscellaneous applications is expected to increase.

By User

Academic Research Institutes:

Academic research institutes are significant users of nucleic acid isolation machines, as they engage in various studies that require meticulous nucleic acid extraction processes. These institutions often focus on educational research, where students and researchers gain hands-on experience with molecular techniques. The demand for nucleic acid isolation technologies in academic settings is driven by the need for reliable and versatile extraction methods that can be adapted to different research objectives. As educational institutions increasingly prioritize research in fields such as genomics and molecular biology, the adoption of nucleic acid isolation machines is likely to grow, providing students with valuable practical skills and enhancing the overall quality of research output.

Contract Research Organizations:

Contract research organizations (CROs) play a pivotal role in the nucleic acid isolation machine market, as they provide essential services to pharmaceutical, biotechnology, and academic clients. These organizations often undertake a wide range of research activities, including clinical trials, drug development, and laboratory testing, necessitating efficient nucleic acid extraction methods. CROs are increasingly investing in advanced nucleic acid isolation technologies to improve their operational efficiency and meet the diverse needs of their clients. As the demand for outsourced research services continues to rise, the role of CROs in the nucleic acid isolation market is expected to expand, driving the adoption of innovative technologies.

Diagnostic Centers:

Diagnostic centers are increasingly utilizing nucleic acid isolation machines to enhance their testing capabilities, particularly in the fields of infectious disease diagnostics and genetic testing. The ability to accurately isolate nucleic acids from various biological samples is essential for reliable test results, making these machines crucial for diagnostic centers. As the prevalence of genetic disorders and infectious diseases continues to rise, these facilities are investing in advanced nucleic acid isolation technologies to expand their service offerings and improve patient care. The integration of molecular diagnostics into routine clinical practice is further driving the demand for nucleic acid isolation machines in diagnostic centers, ensuring that they remain at the forefront of medical advancements.

Hospitals:

Hospitals serve as another significant user segment within the nucleic acid isolation machine market, utilizing these technologies to facilitate a range of diagnostic testing processes. The increasing emphasis on rapid and accurate diagnostics, particularly in emergency and critical care settings, is driving the adoption of nucleic acid isolation technologies. Hospitals are increasingly investing in advanced machines that can deliver high-quality nucleic acids from diverse sample types, enabling clinicians to make timely and informed decisions regarding patient care. As the healthcare landscape evolves and the demand for personalized medicine grows, the role of nucleic acid isolation machines in hospitals is likely to expand further, enhancing the overall efficiency of laboratory operations.

By Technology

Column-Based Purification:

Column-based purification technology is one of the most widely utilized methods for nucleic acid isolation, offering a robust and established approach for extracting DNA and RNA. This technology leverages silica-based columns that selectively bind nucleic acids, allowing for efficient separation from contaminants. Column-based methods are known for their high purity and yield, making them suitable for a wide range of applications, including sequencing, cloning, and quantitative PCR. As researchers increasingly prioritize reproducibility and accuracy in their experiments, the demand for column-based purification technologies is expected to sustain its growth in the nucleic acid isolation machine market.

Magnetic Bead-Based Purification:

Magnetic bead-based purification has gained significant popularity due to its ease of use and efficiency in isolating nucleic acids. This technology utilizes magnetic beads coated with nucleic acid-binding ligands, allowing for rapid separation of nucleic acids from complex mixtures through a simple magnetic attraction process. The adaptability of magnetic bead-based methods to various sample types and their compatibility with automation make them increasingly appealing to laboratories seeking to enhance throughput and reduce hands-on time. As the demand for rapid and reliable nucleic acid extraction continues to rise, magnetic bead-based purification technologies are expected to capture a sizable share of the market.

Reagent-Based Purification:

Reagent-based purification methods involve the use of specialized chemical reagents to facilitate the isolation of nucleic acids from biological samples. These methods are often simpler and more cost-effective than column-based or bead-based approaches, making them attractive to laboratories with budget constraints. Reagent-based purification technologies are particularly useful for isolation from low-yield samples, as they allow for efficient extraction with minimal loss. As laboratories continue to seek versatile and affordable nucleic acid isolation solutions, the demand for reagent-based purification technologies is expected to remain steady, particularly among smaller research facilities.

Others:

Other technologies utilized for nucleic acid isolation include methods such as ultrafiltration and precipitation techniques that offer alternative approaches to traditional extraction methods. These technologies may be less common than column and bead-based methods but still play a crucial role in specific applications where traditional techniques may not be suitable. For example, ultrafiltration techniques can be advantageous for separating nucleic acids based on size, while precipitation methods can be useful for concentrating nucleic acids from large volumes of samples. As research requires increasingly diverse and specialized nucleic acid isolation techniques, the demand for these alternative approaches is expected to grow within the market.

By Region

The North American region holds the largest market share in the nucleic acid isolation machine market, accounting for approximately 40% of the global market in 2025. The region's dominance can be attributed to the presence of leading biotechnology and pharmaceutical companies, as well as well-established research institutions and universities that drive demand for advanced nucleic acid extraction technologies. Moreover, the growing prevalence of genetic disorders and the increasing emphasis on precision medicine are further fueling market growth in North America. The region is expected to maintain a robust CAGR of 8% during the forecast period, driven by continuous investments in research and development activities aimed at advancing molecular diagnostics.

In Europe, the nucleic acid isolation machine market is expected to experience substantial growth, anticipated to account for 30% of the total market share by 2035. The European region is witnessing a surge in research initiatives focused on genomics and molecular biology, which is driving the demand for nucleic acid isolation technologies. Additionally, the increasing number of clinical research projects and collaborations among academic and industrial entities are contributing to market expansion. The Asia Pacific region is also emerging as a significant market for nucleic acid isolation machines, predicted to reach around 25% of the global market share due to rising investments in healthcare infrastructure and biotechnological advancements in countries like China and India.

Opportunities

The nucleic acid isolation machine market presents numerous opportunities for growth, particularly in the context of rising global health challenges and advancements in biotechnology. The increasing incidence of genetic disorders, coupled with the growing prevalence of infectious diseases, creates an urgent demand for accurate and efficient diagnostic tools. As healthcare systems worldwide prioritize the adoption of molecular diagnostics to enhance patient care, the market for nucleic acid isolation technologies is expected to expand. Moreover, the increasing focus on research and development, particularly in genomics and personalized medicine, is likely to drive innovation and the introduction of novel nucleic acid isolation products, opening new avenues for market players to explore.

Furthermore, as emerging economies continue to invest in their healthcare infrastructure and research capabilities, there is significant potential for market growth in these regions. Companies that tailor their offerings to meet the specific needs of emerging markets and develop cost-effective solutions will likely experience substantial opportunities for expansion. Additionally, the ongoing trend of automation in laboratories presents a unique opportunity for manufacturers to innovate and provide advanced nucleic acid isolation machines that enhance throughput and efficiency. By leveraging these growth opportunities, industry players can position themselves for long-term success in the evolving nucleic acid isolation market.

Threats

Despite the promising outlook for the nucleic acid isolation machine market, several threats could impact its growth trajectory. One of the primary concerns is the rapid pace of technological advancements, which can make existing products obsolete and drive up competition among manufacturers. As new nucleic acid isolation technologies are developed, companies must continuously innovate to keep pace with changing market demands, which could strain resources and impede profitability. Furthermore, the high cost of advanced nucleic acid isolation machines may deter smaller laboratories or research institutions from investing in the latest technologies, potentially limiting market growth.

Another threat to the nucleic acid isolation machine market is the regulatory landscape surrounding the use of molecular diagnostics and biotechnology products. Stringent regulations and the lengthy approval processes for new diagnostic technologies can hinder timely market entry for innovative nucleic acid isolation solutions. Additionally, the market may face challenges from alternative technologies or methods that could replace traditional nucleic acid isolation techniques, further intensifying competition. Companies must remain vigilant and adaptable to navigate these threats effectively while continuing to deliver high-quality products that meet the evolving needs of their customers.

Competitor Outlook

• Qiagen N.V.
• Thermo Fisher Scientific Inc.
• Agilent Technologies, Inc.
• Roche Diagnostics
• Bio-Rad Laboratories, Inc.
• Merck KGaA
• Zymo Research Corp.
• Promega Corporation
• Illumina, Inc.
• Takara Bio Inc.
• Hamilton Company
• Beckman Coulter, Inc.
• New England Biolabs, Inc.
• Genetic Technologies Limited
• SABiosciences Corporation

The competitive landscape of the nucleic acid isolation machine market is characterized by the presence of several key players who are actively engaged in product innovation, strategic collaborations, and mergers and acquisitions. Leading companies such as Qiagen N.V., Thermo Fisher Scientific Inc., and Agilent Technologies, Inc. dominate the market due to their extensive product portfolios and strong brand recognition. These companies are investing heavily in research and development to introduce next-generation nucleic acid isolation technologies that cater to the diverse needs of various end-users. Additionally, strategic partnerships with academic institutions and research organizations are helping these companies to expand their market presence and enhance their product offerings to address specific research challenges faced by their clients.

Thermo Fisher Scientific Inc. stands out as a prominent player in the nucleic acid isolation market, with a comprehensive range of products that cater to different extraction needs. Their innovative solutions, such as the KingFisher Flex system, exemplify the company's commitment to advancing automation in the laboratory setting. This platform is designed to facilitate rapid nucleic acid isolation across multiple sample types, thereby enhancing laboratory efficiency and throughput. Furthermore, Thermo Fisher's acquisition of other biotechnology firms has bolstered its market position, allowing the company to expand its technological capabilities and improve its product offerings continuously.

Qiagen N.V. is another key player in the nucleic acid isolation machine market, renowned for its diverse product range and commitment to innovation. The company's QIAcube systems demonstrate its focus on automation, providing researchers with convenient and efficient nucleic acid extraction methods. Qiagen's strategic initiatives, including collaborations with academic institutions and research organizations, have strengthened its position in the market and enhanced its ability to offer tailored solutions that meet the specific needs of various sectors. With a focus on expanding its presence in emerging markets, Qiagen is well-positioned to capture growth opportunities in the nucleic acid isolation machine market.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Merck KGaA
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Qiagen N.V.
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Illumina, Inc.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Takara Bio Inc.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Hamilton Company
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Roche Diagnostics
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Promega Corporation
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Zymo Research Corp.
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Beckman Coulter, Inc.
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 New England Biolabs, Inc.
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 SABiosciences Corporation
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Agilent Technologies, Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Bio-Rad Laboratories, Inc.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Genetic Technologies Limited
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Thermo Fisher Scientific Inc.
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Nucleic Acid Isolation Machine Sales Market, By User
    • 6.1.1 Academic Research Institutes
    • 6.1.2 Contract Research Organizations
    • 6.1.3 Diagnostic Centers
    • 6.1.4 Hospitals
    • 6.1.5 Pharmaceutical and Biotechnology Companies
  • 6.2 Nucleic Acid Isolation Machine Sales Market, By Technology
    • 6.2.1 Column-Based Purification
    • 6.2.2 Magnetic Bead-Based Purification
    • 6.2.3 Reagent-Based Purification
    • 6.2.4 Others
  • 6.3 Nucleic Acid Isolation Machine Sales Market, By Application
    • 6.3.1 Research Institutes
    • 6.3.2 Biotechnology Companies
    • 6.3.3 Hospitals and Diagnostic Centers
    • 6.3.4 Pharmaceutical Companies
    • 6.3.5 Others
  • 6.4 Nucleic Acid Isolation Machine Sales Market, By Product Type
    • 6.4.1 Automated Nucleic Acid Isolation Machines
    • 6.4.2 Semi-Automated Nucleic Acid Isolation Machines
    • 6.4.3 Manual Nucleic Acid Isolation Kits

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Nucleic Acid Isolation Machine Sales Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Nucleic Acid Isolation Machine Sales market is categorized based on

By Product Type

• Automated Nucleic Acid Isolation Machines
• Semi-Automated Nucleic Acid Isolation Machines
• Manual Nucleic Acid Isolation Kits

By Application

• Research Institutes
• Biotechnology Companies
• Hospitals and Diagnostic Centers
• Pharmaceutical Companies
• Others

By User

• Academic Research Institutes
• Contract Research Organizations
• Diagnostic Centers
• Hospitals
• Pharmaceutical and Biotechnology Companies

By Technology

• Column-Based Purification
• Magnetic Bead-Based Purification
• Reagent-Based Purification
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Qiagen N.V.
• Thermo Fisher Scientific Inc.
• Agilent Technologies, Inc.
• Roche Diagnostics
• Bio-Rad Laboratories, Inc.
• Merck KGaA
• Zymo Research Corp.
• Promega Corporation
• Illumina, Inc.
• Takara Bio Inc.
• Hamilton Company
• Beckman Coulter, Inc.
• New England Biolabs, Inc.
• Genetic Technologies Limited
• SABiosciences Corporation